Abstract

Pulse oximetry screening (POS) has been shown to be an effective, non-invasive investigation that can detect up to 50–70% of previously undiagnosed congenital heart defects (CHDs). The aims of this study were to assess the accuracy of POS in detection of CHDs and its impact on clinical practice. All eligible newborn infants born between 1 Jan 2015 and 31 Dec 2019 in a busy regional neonatal unit were included in this prospective observational study. A positive POS was classified as two separate measurements of oxygen saturation < 95%, or a difference of > 2% between pre- and post-ductal circulations. Overall, 23,614 infants had documented POS results. One hundred eighty nine (0.8%) infants had a true positive result: 6 had critical CHDs, 9 serious or significant CHDs, and a further 156/189 (83%) infants had significant non-cardiac conditions. Forty-three infants who had a normal POS were later diagnosed with the following categories of CHDs post-hospital discharge: 1 critical, 15 serious, 20 significant and 7 non-significant CHDs. POS sensitivity for detection of critical CHD was 85.7%, whereas sensitivity was only 33% for detection of major CHDs (critical and serious) needing surgery during infancy; specificity was 99.3%.Conclusion: Pulse oximetry screening showed moderate to high sensitivity in detection of undiagnosed critical CHDs; however, it failed to detect two-third of major CHDs. Our study further emphasises the significance of adopting routine POS to detect critical CHDs in the clinical practice. However, it also highlights the need to develop new, innovative methods, such as perfusion index, to detect other major CHDs missed by current screening tools.What is Known:• Pulse oximetry screening is cost effective, acceptable, easy to perform and has moderate sensitivity and high specificity in detection of critical congenital heart defects.• Pulse oximetry screening has been implemented many countries including USA for detection of critical congenital heart defects, but it is not currently recommended by the UK National Screening Committee.What is New:• To our knowledge, this is the first study describing postnatal detection and presentation of all the infants with congenital heart defects over a period of 5 years, including those not detected on the pulse oximetry screening, on the clinical practice. • It emphasises that further research required to detect critical congenital heart defects and other major CHDs which can be missed on the screening tools currently employed in clinical practice.

Highlights

  • Congenital heart disease, sepsis and lower respiratory tract infections remain the most common causes of neonatal mortality [1]

  • Of the 27,170 infants born during the study period, 25,185 (92.7%) were eligible for pulse oximetry screening, and 1985 (7.3%) were either admitted to NICU before screening or had an antenatal diagnosis of congenital heart defects (CHDs)

  • CHD total detected by pulse oximetry screen significant other diagnoses total sepsis congenital pneumonia pneumothorax meconium aspiration

Read more

Summary

Introduction

Congenital heart disease, sepsis and lower respiratory tract infections remain the most common causes of neonatal mortality [1]. The incidence of congenital heart defects (CHDs) is around 7–9 per 1000 live births [2, 3]; they account for just under 50% of deaths from all congenital anomalies, and up to 10% of all infant deaths in the Western world [4, 5]. Critical CHDs (CCHDs), comprising up to 30% of all CHDs, are defined by conditions needing surgery, intervention or resulting in death, within 1 month after birth [6]. Most of these defects can be corrected if diagnosed and intervened in a timely fashion; late diagnosis is associated with complications such as acute cardiovascular collapse upon closure of the duct-dependent circulation. Poor clinical condition at the time of surgery worsens outcomes and mortality [7, 8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call